CY1109221T1 - Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum - Google Patents
Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantumInfo
- Publication number
- CY1109221T1 CY1109221T1 CY20091100739T CY091100739T CY1109221T1 CY 1109221 T1 CY1109221 T1 CY 1109221T1 CY 20091100739 T CY20091100739 T CY 20091100739T CY 091100739 T CY091100739 T CY 091100739T CY 1109221 T1 CY1109221 T1 CY 1109221T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antigonal
- anfantum
- determinators
- protein
- gene coding
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 208000004554 Leishmaniasis Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε ένα φαρμακευτικό σκεύασμα για την πρόληψη και θεραπεία, της λεϊσμανίασης σε ανθρώπους ή ζώα, το οποίο αποτελείται από:
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11382598P | 1998-12-23 | 1998-12-23 | |
| CA2256124A CA2256124C (en) | 1998-12-23 | 1998-12-23 | Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans |
| EP05109393A EP1624063B1 (en) | 1998-12-23 | 1999-12-23 | Chimeric gene encoding the antigenic determinants of four proteins of L. infantum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109221T1 true CY1109221T1 (el) | 2014-07-02 |
Family
ID=25680668
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061101190T CY1105331T1 (el) | 1998-12-23 | 2006-08-24 | Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum |
| CY20091100739T CY1109221T1 (el) | 1998-12-23 | 2009-07-14 | Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum |
| CY2016033C CY2016033I2 (el) | 1998-12-23 | 2016-10-20 | Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061101190T CY1105331T1 (el) | 1998-12-23 | 2006-08-24 | Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY2016033C CY2016033I2 (el) | 1998-12-23 | 2016-10-20 | Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1141305B1 (el) |
| CN (1) | CN1158387C (el) |
| AT (2) | ATE429498T1 (el) |
| AU (1) | AU759316B2 (el) |
| BE (1) | BE2016C049I2 (el) |
| BG (1) | BG65569B1 (el) |
| BR (1) | BRPI9916549B8 (el) |
| CY (3) | CY1105331T1 (el) |
| CZ (1) | CZ20012360A3 (el) |
| DE (2) | DE69931518T2 (el) |
| DK (1) | DK1141305T3 (el) |
| ES (2) | ES2326174T3 (el) |
| HR (1) | HRP20010554A2 (el) |
| HU (1) | HUP0104743A3 (el) |
| IL (2) | IL143956A0 (el) |
| LU (1) | LU93259I2 (el) |
| MX (1) | MXPA01006548A (el) |
| NL (1) | NL300830I2 (el) |
| PT (2) | PT1141305E (el) |
| SI (1) | SI1624063T1 (el) |
| TR (1) | TR200102655T2 (el) |
| WO (1) | WO2000039298A1 (el) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613337B1 (en) * | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| ES2169995B1 (es) * | 2000-04-17 | 2003-12-01 | Leti Lab | Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno. |
| US6673351B1 (en) | 2001-03-16 | 2004-01-06 | Astralis, Llc | Compositions and methods for the treatment and clinical remission of psoriasis |
| WO2006058243A2 (en) * | 2004-11-24 | 2006-06-01 | Yale University | Leishmania antigens and related compositions and uses |
| MX2010007831A (es) * | 2008-01-18 | 2011-06-20 | Leti S L Unipersonal Lab | Vacuna que comprende un extracto de proteina ribosomal (rpe) y opcionalmente un adyuvante promotor de th-1. |
| CA2767865A1 (en) * | 2009-07-13 | 2011-01-20 | Laboratorios Leti, S.L. | Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
| SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
| BR102019003639A2 (pt) * | 2019-02-22 | 2021-11-16 | Fundação Oswaldo Cruz | Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro |
| ES2795149B2 (es) | 2020-06-08 | 2022-07-04 | Univ Madrid Complutense | Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos |
| CN112662694A (zh) * | 2020-12-25 | 2021-04-16 | 康九生物科技(长春)有限公司 | 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0703295A1 (en) * | 1994-09-26 | 1996-03-27 | Institut Pasteur | Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein |
| US5912166A (en) * | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
| ES2133236B1 (es) * | 1997-06-27 | 2000-04-16 | Leti Lab | Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida. |
-
1999
- 1999-12-23 AT AT05109393T patent/ATE429498T1/de not_active IP Right Cessation
- 1999-12-23 EP EP99967987A patent/EP1141305B1/en not_active Expired - Lifetime
- 1999-12-23 PT PT99967987T patent/PT1141305E/pt unknown
- 1999-12-23 TR TR2001/02655T patent/TR200102655T2/xx unknown
- 1999-12-23 CN CNB998163066A patent/CN1158387C/zh not_active Expired - Lifetime
- 1999-12-23 ES ES05109393T patent/ES2326174T3/es not_active Expired - Lifetime
- 1999-12-23 CZ CZ20012360A patent/CZ20012360A3/cs unknown
- 1999-12-23 DK DK99967987T patent/DK1141305T3/da active
- 1999-12-23 ES ES99967987T patent/ES2273519T3/es not_active Expired - Lifetime
- 1999-12-23 AU AU24342/00A patent/AU759316B2/en not_active Expired
- 1999-12-23 IL IL14395699A patent/IL143956A0/xx unknown
- 1999-12-23 BR BRPI9916549A patent/BRPI9916549B8/pt not_active IP Right Cessation
- 1999-12-23 HU HU0104743A patent/HUP0104743A3/hu unknown
- 1999-12-23 WO PCT/EP1999/010441 patent/WO2000039298A1/en active IP Right Grant
- 1999-12-23 DE DE69931518T patent/DE69931518T2/de not_active Expired - Lifetime
- 1999-12-23 PT PT05109393T patent/PT1624063E/pt unknown
- 1999-12-23 AT AT99967987T patent/ATE327332T1/de active
- 1999-12-23 SI SI9931029T patent/SI1624063T1/sl unknown
- 1999-12-23 DE DE69940793T patent/DE69940793D1/de not_active Expired - Lifetime
- 1999-12-23 MX MXPA01006548A patent/MXPA01006548A/es active IP Right Grant
-
2001
- 2001-06-24 IL IL143956A patent/IL143956A/en not_active IP Right Cessation
- 2001-07-23 HR HR20010554A patent/HRP20010554A2/hr not_active Application Discontinuation
- 2001-07-23 BG BG105725A patent/BG65569B1/bg unknown
-
2006
- 2006-08-24 CY CY20061101190T patent/CY1105331T1/el unknown
-
2009
- 2009-07-14 CY CY20091100739T patent/CY1109221T1/el unknown
-
2016
- 2016-09-22 NL NL300830C patent/NL300830I2/nl unknown
- 2016-10-06 BE BE2016C049C patent/BE2016C049I2/nl unknown
- 2016-10-06 LU LU93259C patent/LU93259I2/fr unknown
- 2016-10-20 CY CY2016033C patent/CY2016033I2/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109221T1 (el) | Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum | |
| CY1119168T1 (el) | Φαρμακευτικο παρασκευασμα που περιεχει οξυκωδονη και ναλοξονη | |
| DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
| CY1116385T1 (el) | Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β | |
| BRPI9912663B8 (pt) | vacina contra cáncer e polipeptìdeo. | |
| BR9909668A (pt) | Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções | |
| DE69905170T2 (de) | Thiazolopyrimidinderivate | |
| BR0309665A (pt) | Tratamento de deficiência de alfa-galactosidase a | |
| DK0784703T3 (da) | Lamininkæder: Diagnostisk og terapeutisk anvendelse | |
| CY1105309T1 (el) | Συμπλεγμα εμβολιου που προοριζεται για προληψη και θepαπεια των λεϊσμανιασεων | |
| CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
| NO20005608L (no) | Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav | |
| DE69915690D1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| PT983300E (pt) | Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia | |
| DE69514928D1 (de) | Gegen protozoen wirksamezyklische tetrapeptide | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| DE69529295D1 (de) | Chemische proteindenaturierungsbehandlung | |
| DE602004012759D1 (de) | Behandlung von fibrosen | |
| HUP9901183A2 (hu) | Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére | |
| BR0311596A (pt) | Uso de uk114 no tratamento de leishmaniose | |
| DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin | |
| MX9601346A (es) | Antigeno novedoso de trypanosoma cruzi y el gen que codifica para este ultimo; y su aplicacion para la deteccion de la enfermedad de chagas. | |
| DE10192165D2 (de) | neimittel zur Behandlung von Immunreaktionen am Auge | |
| RU99111064A (ru) | Средство для лечения и профилактики инфекционных заболеваний и отравлений животных и птиц, повышающее их продуктивность и сохранность | |
| KR960014502U (ko) | 생수 대장균 및 바이러스 멸균기기 |